Avobenzone Degradation and Sunscreen Stability Testing: What Cosmetic Brands Need to Know Before Launch

In a 2021 study, FDA researchers detected measurable blood concentrations of avobenzone after just four applications of a commercially available sunscreen. The headlines focused on absorption. Almost no one asked the follow-up question: was the avobenzone in those products still chemically intact enough to absorb UVA radiation by application four?

That second question—whether active ingredients remain photochemically functional after manufacture, shelf storage, and actual sun exposure—is what sunscreen stability testing is really about. And it’s where a surprising number of brands running their first launch discover problems they weren’t expecting.

The Avobenzone Problem: Why UVA Protection Is Harder to Stabilize Than It Looks

Avobenzone (butyl methoxydibenzoylmethane) is the most widely used UVA filter in US sunscreens. It absorbs well across the 320–400 nm UVA spectrum, it’s been approved for OTC use since 1988, and it’s permitted at concentrations up to 3% under 21 CFR Part 352. On paper, it’s the workhorse of broad-spectrum UVA protection.

The catch: avobenzone is inherently photounstable. Under UV radiation, the molecule undergoes a photodegradation reaction—shifting from its UV-absorbing keto form to a relatively inactive enol form—and loses most of its protective capacity. Multiple peer-reviewed studies have documented losses of 50% to 90% within one hour of UV exposure when avobenzone is used without a photostabilizer. That’s not trace degradation. That’s a formula providing minimal UVA protection by the time someone finishes a typical beach morning.

The industry’s solution is photostabilizers: co-ingredients that either absorb avobenzone’s photodegradation products or quench the excited triplet state before the destructive reaction proceeds. Octocrylene is the most common US-approved option. Tinosorb S and Tinosorb M—far more effective photostabilizers—remain unapproved for OTC use in the US, though they’re standard in EU formulations. Mexoryl SX is available in the US, but its use is tied to specific licensing arrangements through L’Oréal’s NDA.

What this means practically: even if your formula contains both avobenzone and octocrylene, the ratio has to be right for your specific matrix. A molar ratio that performs adequately in an oil-in-water emulsion may degrade significantly in an anhydrous stick or an aerosol spray. There’s no one-size-fits-all formula; there’s only testing.

What Sunscreen Stability Testing Actually Covers

Because FDA classifies all sunscreens as OTC drugs—not cosmetics—the stability testing framework follows pharmaceutical conventions, not cosmetic shelf-life norms. A moisturizer might go through a 12-week accelerated cosmetic stability study. A sunscreen needs a program structured around ICH Q1A(R2), the internationally recognized pharmaceutical stability guideline, and any qualified cosmetic testing laboratory doing this work correctly will tell you so upfront.

ICH Q1A(R2) defines three study arms that matter most for sunscreen formulations:

Long-term stability: 25°C / 60% relative humidity, with test intervals at 0, 3, 6, 9, 12, 18, and 24 months. This generates the shelf-life data that appears on your label.

Accelerated stability: 40°C / 75% RH for six months, sampled at 0, 3, and 6 months. A clean six-month accelerated result can support a 24-month shelf-life claim before long-term data matures—a common approach when brands need to launch before two years of data are in hand.

Intermediate stability: 30°C / 65% RH, invoked when accelerated results show trending failures—phase separation, viscosity shifts, or active ingredient loss that warrants a slower-temperature investigation.

At each timepoint, a complete sunscreen stability panel should include: SPF value, UVA protection factor or critical wavelength, active ingredient concentration by HPLC, pH, viscosity, appearance and color, and microbial limits. Labs that cut corners—tracking SPF and appearance only, without the HPLC concentration data—leave brands exposed. An SPF value can remain superficially stable across timepoints while individual active ingredient concentrations shift through ingredient interactions, precipitation, or oxidation. The SPF number alone won’t catch that.

Photostability Under ICH Q1B: The Test Most Brands Skip

ICH Q1B is the guideline specifically addressing photostability, and for sunscreens it’s arguably the most revealing test in the entire stability program. The protocol exposes samples to a defined combination of visible and UV radiation—at minimum 1.2 million lux-hours of cool white fluorescent light and 200 Wh/m² of UV radiation—and then requires comparison of active concentration, appearance, and performance metrics before and after exposure.

The practical question is simple: does your SPF hold after the light exposure? For most chemical UV filters, the answer depends entirely on the formulation. We routinely see products where labeled SPF is confirmed at time zero and confirmed again after thermal stability, but loses 15–25% of its in vitro measurement after the ICH Q1B exposure sequence. In a pharmaceutical drug, a 10% assay drop triggers a formal OOS (out-of-specification) investigation. For sunscreens, the FDA monograph doesn’t specify a photostability acceptance criterion directly, but a meaningful SPF loss after the protocol creates a labeling accuracy problem that’s hard to defend under a regulatory review—or in litigation.

Brands building their first sunscreen often exclude ICH Q1B to save time or cost. That decision tends to surface later: either at the consumer complaint stage (“this stops working after an hour in the sun”) or during a retail partner’s compliance audit. Running photostability in parallel with thermal stability costs less than fixing the problem after a product launch.

Reading a Sunscreen COA from a Cosmetic Testing Laboratory

A certificate of analysis from a stability timepoint tells you more than it might initially appear—but only if you know what each row actually means.

Active ingredient by HPLC is the most important number on the page. An avobenzone assay starting at 100.2% of label claim that drifts to 88.5% at six-month accelerated is telling a story. Whether that story ends in a passing result or a reformulation depends on whether you set a specification before testing began. Most cosmetic testing labs recommend a 90–110% acceptance range for actives, mirroring the standard pharmaceutical convention. If you didn’t set a spec before running stability, you have data but no standard to measure it against—which is not a compliance package.

SPF value (in vitro) per ISO 24443 is a useful trend indicator across stability timepoints, but it shouldn’t be the sole basis for your labeled SPF claim. For the label itself, FDA guidance calls for in vivo testing per the SPF test procedure in 21 CFR Part 352, typically involving at least 10 panelists per the monograph protocol.

Microbial limits follow USP <61> and <62> for OTC drug products—stricter than cosmetic requirements. Total aerobic microbial count (TAMC) ≤ 10² CFU/g is standard, with absence requirements for Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. A cosmetic preservative that performs adequately in a lotion at cosmetic acceptance criteria may not clear the OTC drug limits.

pH is a quieter but important indicator. A shift of more than ±0.5 pH units across timepoints warrants investigation, particularly for emulsion systems where emulsifier performance and preservative activity are pH-sensitive. A formula that becomes more acidic under accelerated conditions may be degrading through a mechanism that won’t be obvious from appearance alone.

Building a Stability Program That Survives FDA Scrutiny

The regulatory landscape for sunscreens has been shifting. The FDA’s 2019 proposed rule under the Sunscreen Innovation Act established that only zinc oxide and titanium dioxide are currently classified as GRASE (Generally Recognized as Safe and Effective). The other 12 commonly used chemical UV filters—including avobenzone, oxybenzone, octinoxate, homosalate, and octocrylene—remain in “not GRASE pending data” status. That’s not a prohibition; brands can and do market these ingredients. But it signals that FDA scrutiny in this category is heightened, and stability dossiers that hold up need to be built carefully.

Here’s what a well-structured program looks like, from the perspective of working through these studies daily:

1. Set specifications before you run stability. This sounds obvious, and yet it’s the most common gap we see. A stability study without pre-defined acceptance criteria generates data, not a compliance package.

2. Run photostability in parallel with thermal stability—not after. Adding the ICH Q1B exposure sequence as an afterthought at the end of a 12-month study adds months to your timeline. Parallel execution adds a few weeks to lab scheduling and nothing to your launch date.

3. Retain reference samples at −20°C from each manufactured lot. If a stability failure appears at month 12, you need original samples to run confirmatory testing and rule out testing artifacts or sample handling errors.

4. Test SPF both before and after the photostability exposure. Many cosmetic testing labs offer this as a bundled protocol. The before/after delta is the single most informative data point the Q1B study generates, and it’s the number that will define your reformulation conversation if results are unfavorable.

5. Match storage conditions to your actual supply chain. If your product moves through distribution centers in the San Bernardino Valley or Arizona during summer, the 25°C long-term condition may not represent your real-world storage environment. A 30°C intermediate arm is often more representative of southern California supply chain reality—and it’s a conversation worth having with your testing lab before protocols are finalized.

The difference between a stability dossier that clears an FDA desk review and one that generates a 483 observation is usually not which tests were run. It’s whether specifications were pre-defined, whether photostability was included, and whether the data package is complete enough to tell a coherent story about product quality across the full intended shelf life.

Sunscreen formulation has always been more complicated than the SPF number on the label suggests. The stability program is where that complexity either gets managed—or gets deferred until a more expensive moment.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• FDA OTC Drug Compliance and Regulatory Documentation Consulting — Aurora TIC helps regulated companies build audit-ready documentation for OTC drug filings, software validation, and FDA submissions.
• UV Filter Raw Material Testing and Supplier Qualification — Ayah Labs offers COA verification and identity testing for cosmetic active ingredients including UV filters and emollients.